BZYR (Burzynski Research Institute) EBIT per Share : $-0.01 (TTM As of Nov. 2024)

View and export this data going back to . Start your Free Trial

What is Burzynski Research Institute EBIT per Share?

Burzynski Research Institute's EBIT per Share for the three months ended in Nov. 2024 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.01.

During the past 5 years, the average EBIT per Share Growth Rate was 7.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Burzynski Research Institute's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Burzynski Research Institute was 32.60% per year. The lowest was -11.50% per year. And the median was 5.30% per year.

BZYR's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 4.2
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Burzynski Research Institute's EBIT for the three months ended in Nov. 2024 was $-0.35 Mil.

Burzynski Research Institute EBIT per Share Historical Data

The historical data trend for Burzynski Research Institute's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burzynski Research Institute EBIT per Share Chart

Burzynski Research Institute Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

EBIT per Share

Get a 7-Day Free Trial

-0.01

Burzynski Research Institute Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
EBIT per Share	Get a 7-Day Free Trial															-	-	-	-	-

Burzynski Research Institute EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Burzynski Research Institute's EBIT per Share for the fiscal year that ended in Feb. 2024 is calculated as

	EBIT per Share		(A: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.335	/	131.448
=	-0.01

Burzynski Research Institute's EBIT per Share for the quarter that ended in Nov. 2024 is calculated as

	EBIT per Share		(Q: Nov. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.352	/	131.448
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

Burzynski Research Institute (OTCPK:BZYR) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Burzynski Research Institute EBIT per Share Related Terms

Thank you for viewing the detailed overview of Burzynski Research Institute's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Burzynski Research Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Burzynski Research Institute Inc (OTCPK:BZYR) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

9432 Katy Freeway, Houston, TX, USA, 77055

Website

http://www.burzynskiresearch.com

Burzynski Research Institute Inc operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.

Executives

Monika Szopa-paszkowiak	director	9432 KATY FWY #200, HOUSTON TX 77055
Frederick Richard Schiff	director	9432 KATY FREEWAY, HOUSTON TX 77055
Barbara Burzynski	director, 10 percent owner	9432 KATY FREEWAY, HOUSTON TX 77055
Carlton Hazlewood	director	9432 KATY FREEWAY, HOUSTON TX 77055
Patryk Goscianski	officer: Secretary and Treasurer	9432 KATY FREEWAY, HOUSTON TX 77055
Gregory Burzynski	director	9432 KATY FREEWAY, HOUSTON TX 77055
Tomasz Janicki	officer: VP of Clinical Trials	9432 KATY FREEWAY, HOUSTON TX 77055
Michael Driscoll	director	9432 KATY FREEWAY, HOUSTON TX 77055
Stanislaw Burzynski	director, 10 percent owner, officer: President	9432 KATY FREEWAY, HOUSTON TX 77055
Dudley Reece Anderson	officer: Chief Financial Officer	9432 OLD KATY RD., SUITE 200, HOUSTON TX 77055

Burzynski Research Institute Headlines

No Headlines